Zosano Company Logo
Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11
June 02, 2022 08:00 ET | Zosano Pharma Corporation
FREMONT, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on June 1, 2022 it filed a voluntary...
Zosano Company Logo
Zosano Pharma Reports First Quarter 2022 Financial Results
May 13, 2022 16:00 ET | Zosano Pharma Corporation
FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended...
Zosano Company Logo
Zosano Pharma Provides Corporate Update
April 29, 2022 16:00 ET | Zosano Pharma Corporation
FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a corporate update. On April 14, 2022, the...
Zosano Company Logo
Zosano Pharma Announces Reverse Stock Split Effective Today
April 11, 2022 08:00 ET | Zosano Pharma Corporation
FREMONT, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its Board of Directors has approved a...
Zosano Company Logo
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results
March 17, 2022 16:05 ET | Zosano Pharma Corporation
FREMONT, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and...
Zosano Company Logo
Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and Warrants
February 08, 2022 21:55 ET | Zosano Pharma Corporation
FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced...
Zosano Company Logo
Zosano Pharma Announces Proposed Public Offering of Common Stock and Warrants
February 08, 2022 16:10 ET | Zosano Pharma Corporation
FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it is commencing an underwritten public...
Zosano Company Logo
CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose
January 05, 2022 12:01 ET | Zosano Pharma Corporation
FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- In a press release published under the same headline today by Zosano Pharma Corporation (Nasdaq:ZSAN), a measurement was incorrectly stated as...
Zosano Company Logo
Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose
January 05, 2022 09:20 ET | Zosano Pharma Corporation
FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the publication of Phase 1 clinical trial...
Zosano Company Logo
Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. Yang
December 13, 2021 16:30 ET | Zosano Pharma Corporation
FREMONT, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced changes to its board of directors, including...